BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

937 related articles for article (PubMed ID: 27603132)

  • 1. Therapeutic targeting of splicing in cancer.
    Lee SC; Abdel-Wahab O
    Nat Med; 2016 Sep; 22(9):976-86. PubMed ID: 27603132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Pathways: Understanding and Targeting Mutant Spliceosomal Proteins.
    Yoshimi A; Abdel-Wahab O
    Clin Cancer Res; 2017 Jan; 23(2):336-341. PubMed ID: 27836865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant RNA splicing and therapeutic opportunities in cancers.
    Yamauchi H; Nishimura K; Yoshimi A
    Cancer Sci; 2022 Feb; 113(2):373-381. PubMed ID: 34812550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA components of the spliceosome regulate tissue- and cancer-specific alternative splicing.
    Dvinge H; Guenthoer J; Porter PL; Bradley RK
    Genome Res; 2019 Oct; 29(10):1591-1604. PubMed ID: 31434678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Targeting of RNA Splicing in Cancer.
    Bonner EA; Lee SC
    Genes (Basel); 2023 Jun; 14(7):. PubMed ID: 37510283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spliceosomal factor mutations and mis-splicing in MDS.
    Hershberger CE; Daniels NJ; Padgett RA
    Best Pract Res Clin Haematol; 2020 Sep; 33(3):101199. PubMed ID: 33038983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Splicing-factor alterations in cancers.
    Anczuków O; Krainer AR
    RNA; 2016 Sep; 22(9):1285-301. PubMed ID: 27530828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting splicing factors for cancer therapy.
    Bashari A; Siegfried Z; Karni R
    RNA; 2023 Apr; 29(4):506-515. PubMed ID: 36697261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative splicing and cancer: a systematic review.
    Zhang Y; Qian J; Gu C; Yang Y
    Signal Transduct Target Ther; 2021 Feb; 6(1):78. PubMed ID: 33623018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SnapShot: Splicing Alterations in Cancer.
    Rahman MA; Krainer AR; Abdel-Wahab O
    Cell; 2020 Jan; 180(1):208-208.e1. PubMed ID: 31951519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting splicing abnormalities in cancer.
    Agrawal AA; Yu L; Smith PG; Buonamici S
    Curr Opin Genet Dev; 2018 Feb; 48():67-74. PubMed ID: 29136527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [RNA splicing dysregulation in hematological malignancies].
    Yoshida M; Yamauchi H; Sakumoto M; Yoshimi A
    Rinsho Ketsueki; 2023; 64(7):646-653. PubMed ID: 37544725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging roles of spliceosome in cancer and immunity.
    Yang H; Beutler B; Zhang D
    Protein Cell; 2022 Aug; 13(8):559-579. PubMed ID: 34196950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Splicing factor mutations in the myelodysplastic syndromes: target genes and therapeutic approaches.
    Armstrong RN; Steeples V; Singh S; Sanchi A; Boultwood J; Pellagatti A
    Adv Biol Regul; 2018 Jan; 67():13-29. PubMed ID: 28986033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-canonical functions of spliceosome components in cancer progression.
    Ivanova OM; Anufrieva KS; Kazakova AN; Malyants IK; Shnaider PV; Lukina MM; Shender VO
    Cell Death Dis; 2023 Feb; 14(2):77. PubMed ID: 36732501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired mutations that affect pre-mRNA splicing in hematologic malignancies and solid tumors.
    Scott LM; Rebel VI
    J Natl Cancer Inst; 2013 Oct; 105(20):1540-9. PubMed ID: 24052622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of alternative splicing in cancer: From oncogenesis to drug resistance.
    Sciarrillo R; Wojtuszkiewicz A; Assaraf YG; Jansen G; Kaspers GJL; Giovannetti E; Cloos J
    Drug Resist Updat; 2020 Dec; 53():100728. PubMed ID: 33070093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes.
    Sveen A; Kilpinen S; Ruusulehto A; Lothe RA; Skotheim RI
    Oncogene; 2016 May; 35(19):2413-27. PubMed ID: 26300000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA Splicing and Cancer.
    Wang E; Aifantis I
    Trends Cancer; 2020 Aug; 6(8):631-644. PubMed ID: 32434734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational landscape of RNA-binding proteins in human cancers.
    Neelamraju Y; Gonzalez-Perez A; Bhat-Nakshatri P; Nakshatri H; Janga SC
    RNA Biol; 2018 Jan; 15(1):115-129. PubMed ID: 29023197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.